Improving the transition from pediatric to adult epilepsy care: An expert opinion

Flavio Villani1, Francesca Bisulli2, Francesca Darra3

  • 1Division of Clinical Neurophysiology and Epilepsy Center, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

PubMed

Insights

Transitioning young people with epilepsy (PwE) to adult care requires a structured approach. The TRUST project developed tools to assess needs and improve this critical phase for better long-term outcomes.

Area of Science:

  • Neurology
  • Developmental Psychology
  • Healthcare Management

Background:

  • Transition from pediatric to adult epilepsy care presents significant challenges for young people, including care discontinuity, stigma, and autonomy issues.
  • Comorbidities in young people with epilepsy (PwE) exacerbate medical and psychosocial difficulties, leading to suboptimal outcomes and inadequate support.
  • Effective multiprofessional transition is vital for maintaining quality of life and addressing critical areas like medication adherence, social integration, and life skills.

Purpose of the Study:

  • To enhance transitional care for young people with epilepsy (PwE) through a holistic, integrated approach.
  • To develop and implement targeted questionnaires for assessing medical and psychosocial needs of PwE and caregivers during transition.
  • To evaluate the effectiveness of the transition process and inform future clinical practice.

Main Methods:

  • The TRUST project involved five macro-regional meetings across Italy with pediatric and adult neurologists to discuss best practices and challenges.
  • Development of targeted questionnaires informed by expert dialogue and focused on systematically assessing medical and psychosocial needs.
  • Combining structured data collection with national expert input to identify and address gaps in current transitional care.

Main Results:

  • Insights from national expert dialogue and macro-regional meetings informed the development of assessment tools.
  • The TRUST project established a framework for a more integrated and multiprofessional approach to epilepsy transition care.
  • Questionnaires were designed to systematically evaluate the needs of PwE and caregivers and the effectiveness of the transition process.

Conclusions:

  • The TRUST project's initiatives aim to bridge existing gaps in transitional care for PwE.
  • Implementing the developed questionnaires into routine clinical practice can facilitate a more seamless and individualized transition.
  • This approach has the potential to improve healthcare provider communication, patient engagement, and long-term outcomes in adult epilepsy care.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
296
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
612
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
205
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
30
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
681